Jpmorgan Chase & CO Veru Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VERU
# of Institutions
123Shares Held
56.8MCall Options Held
668KPut Options Held
531K-
Adage Capital Partners Gp, L.L.C. Boston, MA7.86MShares$5.35 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.65MShares$5.2 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY7.28MShares$4.95 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.2MShares$4.22 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.55MShares$3.78 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $54.5M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....